Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients
Clinical trial NCT01201343 · COMPLETED
Trial details
- NCT number
- NCT01201343
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2010-07-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.